Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1438-15-9

Post Buying Request

1438-15-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1438-15-9 Usage

Common Reference

Chemical structure

Category

Organic compound

Physical State

Colorless solid

Odor

Strong

Solubility

Soluble in water

Application

Organic synthesis and pharmaceutical research

Use as Chiral Auxiliary

In asymmetric synthesis

Use as Resolving Agent

For racemic mixtures

Investigation

Potential use in treatment of various disorders and diseases

Pharmacological Properties

Unique properties that contribute to its potential therapeutic applications

Check Digit Verification of cas no

The CAS Registry Mumber 1438-15-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,4,3 and 8 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1438-15:
(6*1)+(5*4)+(4*3)+(3*8)+(2*1)+(1*5)=69
69 % 10 = 9
So 1438-15-9 is a valid CAS Registry Number.

1438-15-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-amino-3,3-dimethylbutan-2-ol,hydrochloride

1.2 Other means of identification

Product number -
Other names 1-AMINO-3,3-DIMETHYLBUTAN-2-OL HYDROCHLORIDE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1438-15-9 SDS

1438-15-9Downstream Products

1438-15-9Relevant articles and documents

KCNQ Potentiators

-

Paragraph 0046, (2020/08/20)

Small molecule potentiatiors to potassium channels (such as Kv7 potentiators—which are also called KCNQ potentiators), compositions including such compounds, and methods of using such compounds for the treatment of Amyotrophic Lateral Sclerosis and other neurological diseases caused by changes in motor neuron excitability, including, but not limited to, primary lateral sclerosis, pseudobulbar palsy, progressive bulbar palsy, progressive muscular atrophy and epilepsy.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1438-15-9